{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T11:07:51Z","timestamp":1767006471216,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Financial Department of Hebei Province","award":["(2012)2056"],"award-info":[{"award-number":["(2012)2056"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.cancergen.2016.06.006","type":"journal-article","created":{"date-parts":[[2016,7,5]],"date-time":"2016-07-05T18:40:34Z","timestamp":1467744034000},"page":"365-375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Association of programmed death-1 polymorphisms with the risk and prognosis of esophageal squamous cell carcinoma"],"prefix":"10.1016","volume":"209","author":[{"given":"Rong-Miao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Ru","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-En","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2016.06.006_bib0010","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0015","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0020","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nri1349","article-title":"Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity","volume":"4","author":"Chen","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/156800907780006878","article-title":"Costimulation, coinhibition and cancer","volume":"7","author":"Inman","year":"2007","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni1443","article-title":"The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection","volume":"8","author":"Sharpe","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0035","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/85330","article-title":"PD-L2 is a second ligand for PD-1 and inhibits T cell activation","volume":"2","author":"Latchman","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0045","doi-asserted-by":"crossref","first-page":"13866","DOI":"10.1073\/pnas.231486598","article-title":"PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine","volume":"98","author":"Okazaki","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0050","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0055","doi-asserted-by":"crossref","first-page":"9543","DOI":"10.1128\/MCB.25.21.9543-9553.2005","article-title":"CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms","volume":"25","author":"Parry","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1471-4906(01)01888-9","article-title":"PD-1: an inhibitory immunoreceptor involved in peripheral tolerance","volume":"22","author":"Nishimura","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0065","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/cei.12603","article-title":"Low programmed cell death-1 (PD-1) expression in peripheral CD4(+) T cells in Japanese patients with autoimmune type 1 diabetes","volume":"180","author":"Fujisawa","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0070","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.imlet.2014.09.001","article-title":"PD-1 mRNA expression is associated with clinical and viral profile and PD1 3\u2032-untranslated region polymorphism in patients with chronic HBV infection","volume":"162","author":"Zhang","year":"2014","journal-title":"Immunol Lett"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0075","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1365-2249.2011.04463.x","article-title":"Immunogenic and tolerogenic signatures in human immunodeficiency virus (HIV)-infected controllers compared with progressors and a conversion strategy of virus control","volume":"166","author":"Whittall","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0080","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.3748\/wjg.v17.i28.3322","article-title":"Immunostaining of PD-1\/PD-Ls in liver tissues of patients with hepatitis and hepatocellular carcinoma","volume":"17","author":"Wang","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0085","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0090","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00439-009-0781-z","article-title":"PD1 as a common candidate susceptibility gene of subacutesclerosingpanencephalitis","volume":"127","author":"Ishizaki","year":"2010","journal-title":"Hum Genet"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0095","first-page":"178","article-title":"Programmed death-1 gene polymorphism (PD-1.5 C\/T) is associated with gastric cancer","volume":"6","author":"Savabkar","year":"2013","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0100","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.gene.2012.07.059","article-title":"Programmed death-1 gene polymorphism (PD-1.5 C\/T) is associated with colon cancer","volume":"508","author":"Mojtahedi","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0105","first-page":"25","article-title":"PDCD1, CTLA-4 and p53 gene polymorphism and susceptibility to gestational trophoblastic diseases","volume":"54","author":"Dehaghani","year":"2009","journal-title":"J Reprod Med"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10549-011-1440-3","article-title":"PD-1 polymorphisms are associated with sporadic breast cancer in Chinese Han population of Northeast China","volume":"129","author":"Hua","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0115","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.clinbiochem.2013.12.023","article-title":"Programmed death-1 (PD-1) polymorphisms in Chinese patients with esophageal cancer","volume":"47","author":"Qiu","year":"2014","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0120","doi-asserted-by":"crossref","first-page":"18933","DOI":"10.18632\/oncotarget.3662","article-title":"microRNA-4717 differentially interacts with its polymorphic target in the PD1 3\u2032 untranslated region: a mechanism for regulating PD-1 expression and function in HBV-associated liver diseases","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0125","doi-asserted-by":"crossref","first-page":"247637","DOI":"10.1155\/2014\/247637","article-title":"A promoter region polymorphism in PDCD-1 gene is associated with risk of rheumatoid arthritis in the Han Chinese population of Southeastern China","volume":"2014","author":"Liu","year":"2014","journal-title":"Int J Genomics"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0130","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/art.20966","article-title":"A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese","volume":"52","author":"Kong","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0135","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1093\/rheumatology\/ker211","article-title":"Effects of genetic polymorphisms of programmed cell death 1 and its ligands on the development of ankylosing spondylitis","volume":"50","author":"Huang","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0140","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00296-009-1264-1","article-title":"Programmed cell death 1 gene polymorphisms is associated with ankylosing spondylitis in Chinese Han population","volume":"31","author":"Liu","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0145","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.meegid.2015.02.022","article-title":"Genetic variations of IL-28B and PD-1 are in association with the susceptibility and outcomes of HCV infection in Southeast China","volume":"32","author":"Xiao","year":"2015","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0150","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1055\/s-0033-1338134","article-title":"PD-1 gene polymorphism in children with subacutesclerosingpanencephalitis","volume":"44","author":"Piskin","year":"2013","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0155","first-page":"8086","article-title":"Programmed death-1 (PD-1) polymorphism is associated with gastric cardia adenocarcinoma","volume":"8","author":"Tang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0160","first-page":"5832","article-title":"The programmed death-1 gene polymorphism (PD-1.5 C\/T) is associated with non-small cell lung cancer risk in a Chinese Han population","volume":"7","author":"Yin","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0165","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3892\/mco.2014.358","article-title":"PD-1 gene promoter polymorphisms correlate with a poor prognosis in non-small cell lung cancer","volume":"2","author":"Sasaki","year":"2014","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0170","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0175","first-page":"562","article-title":"Incidence and mortality rate of esophageal cancer has decreased during past 40 years in Hebei Province, China","volume":"27","author":"He","year":"2015","journal-title":"Chin J Cancer Res"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0180","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0185","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4254\/wjh.v3.i3.72","article-title":"Polymorphisms in programmed death-1 gene are not associated with chronic HBV infection in Chinese patients","volume":"3","author":"Lv","year":"2011","journal-title":"World J Hepatol"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0190","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/art.20040","article-title":"Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus","volume":"50","author":"Lin","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0195","doi-asserted-by":"crossref","first-page":"e0152448","DOI":"10.1371\/journal.pone.0152448","article-title":"Programmed cell death-1 polymorphisms decrease the cancer risk: a meta-analysis involving twelve case-control studies","volume":"11","author":"Dong","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0200","first-page":"22278","article-title":"Programmeddeath-1 (PD-1) rs2227981 C>T polymorphism is associated with cancersusceptibility: a meta-analysis","volume":"8","author":"Tang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0205","first-page":"13282","article-title":"Association of programmed death-1 gene polymorphism rs2227981 with tumor: evidence from a meta analysis","volume":"8","author":"Mamat","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0210","first-page":"16585","article-title":"Polymorphisms of co-inhibitory molecules (CTLA-4\/PD-1\/PD-L1) and the risk of non-small celllung cancer in a Chinese population","volume":"8","author":"Ma","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0215","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1007\/s11033-010-0542-z","article-title":"Program death 1 (PD1) haplotyping in patients with breast carcinoma","volume":"38","author":"Haghshenas","year":"2011","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0220","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ygyno.2009.10.084","article-title":"Interaction of immunological geneson chromosome 2q33 and IFNG in susceptibility to cervical cancer","volume":"116","author":"Ivansson","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0225","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.meegid.2011.06.004","article-title":"Altered TNF-\u03b1 and IFN-\u03b3 levels associated with PD1 but not TNFA polymorphisms in patients with chronic HBV infection","volume":"11","author":"Zhang","year":"2011","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0230","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.humimm.2010.08.014","article-title":"Association of polymorphisms of programmed cell death-1 gene with chronic hepatitis B virus infection","volume":"71","author":"Zhang","year":"2010","journal-title":"Hum Immunol"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0235","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cancergen.2016.06.006_bib0240","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221077621630206X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221077621630206X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:41:17Z","timestamp":1761896477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221077621630206X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S221077621630206X"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2016.06.006","relation":{},"ISSN":["2210-7762"],"issn-type":[{"type":"print","value":"2210-7762"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of programmed death-1 polymorphisms with the risk and prognosis of esophageal squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2016.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}